Page 45 - Read Online

Page 14 of 15 Okafor et al. Mini-invasive Surg 2024;8:28 https://dx.doi.org/10.20517/2574-1225.2023.128

factors. Arch Otolaryngol Head Neck Surg 2007;133:276-80. DOI PubMed
84. Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope
2009;119:1412-6. DOI PubMed
85. Benfari G, Fusconi M, Ciofalo A, et al. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Acta Otorhinolaryngol
Ital 2008;28:292-7. PubMed PMC
86. Gruber G, Laedrach K, Baumert B, Caversaccio M, Raveh J, Greiner R. Esthesioneuroblastoma: irradiation alone and surgery alone
are not enough. Int J Radiat Oncol Biol Phys 2002;54:486-91. DOI
87. Platek ME, Merzianu M, Mashtare TL, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma:
analysis of the SEER database. Radiat Oncol 2011;6:41. DOI PubMed PMC
88. Schwartz JS, Palmer JN, Adappa ND. Contemporary management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg
2016;24:63-9. DOI PubMed
89. Herr MW, Sethi RK, Meier JC, et al. Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and
massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B
Skull Base 2014;75:58-64. DOI PubMed PMC
90. Tajudeen BA, Arshi A, Suh JD, et al. Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013. J Neurol Surg B Skull
Base 2015;76:43-9. DOI PubMed PMC
91. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution’s experience. Arch
Otolaryngol Head Neck Surg 2006;132:134-8. DOI PubMed
92. Su SY, Bell D, Ferrarotto R, et al. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck
2017;39:1671-9. DOI PubMed
93. Porter AB, Bernold DM, Giannini C, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol
2008;90:201-4. DOI PubMed
94. Lucas JT Jr, Ladra MM, MacDonald SM, et al. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood
Cancer 2015;62:1523-8. DOI PubMed PMC
95. Eich HT, Müller RP, Micke O, Kocher M, Berthold F, Hero B. Esthesioneuroblastoma in childhood and adolescence. Better
prognosis with multimodal treatment? Strahlenther Onkol 2005;181:378-84. DOI PubMed
96. Dumont B, Lemelle L, Cordero C, et al. Esthesioneuroblastoma in children, adolescents and young adults. Bull Cancer
2020;107:934-45. DOI PubMed
97. Howell MC, Branstetter BF 4th, Snyderman CH. Patterns of regional spread for esthesioneuroblastoma. AJNR Am J Neuroradiol
2011;32:929-33. DOI PubMed PMC
98. Noh OK, Lee SW, Yoon SM, et al. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the
multimodality treatment approach? Int J Radiat Oncol Biol Phys 2011;79:443-9. DOI PubMed
99. Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for
elective neck irradiation. Head Neck 2003;25:529-34. DOI PubMed
100. Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette LJ, Eisbruch A. Esthesioneuroblastoma: is there a need for elective neck
treatment? Int J Radiat Oncol Biol Phys 2011;81:e255-61. DOI PubMed
101. Argiris A, Dutra J, Tseke P, Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope
2003;113:155-60. DOI PubMed
102. Gore MR, Zanation AM. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol
Head Neck Surg 2009;135:1030-4. DOI PubMed
103. Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas display a distinct
natural history and outcome. Eur J Cancer 2013;49:1324-34. DOI PubMed
104. Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ. Esthesioneuroblastoma and cervical lymph node metastases: clinical and
therapeutic implications. Acta Otolaryngol 2002;122:215-21. DOI PubMed
105. Konuthula N, Iloreta AM, Miles B, et al. Prognostic significance of Kadish staging in esthesioneuroblastoma: an analysis of the
National Cancer Database. Head Neck 2017;39:1962-8. DOI PubMed PMC
106. Stokes WA, Camilon PR, Banglawala SM, et al. Is sex an independent prognostic factor in esthesioneuroblastoma? Am J Rhinol
Allergy 2015;29:369-72. DOI PubMed
107. Bachar G, Goldstein DP, Shah M, et al. Esthesioneuroblastoma: the princess margaret hospital experience. Head Neck 2008;30:1607-
14. DOI PubMed
108. Diaz EM Jr, Johnigan RH 3rd, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
Head Neck 2005;27:138-49. DOI PubMed
109. Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ. The added value of 18F-FDG PET/CT for evaluation of patients
with esthesioneuroblastoma. J Nucl Med 2012;53:1200-6. DOI PubMed
110. Palmieri DE, Tadokoro KS, Valappil B, et al. DOTATATE PET imaging in olfactory neuroblastoma and association with SSTR
expression. J Neurol Surg B Skull Base 2024;85:439-44. DOI PubMed PMC
111. Dadgar H, Norouzbeigi N, Ahmadzadehfar H, Assadi M. 68Ga-DOTATATE and 18F-FDG PET/CT for the management of
esthesioneuroblastoma of the sphenoclival region. Clin Nucl Med 2020;45:e363-4. DOI PubMed
112. Classe M, Yao H, Mouawad R, et al. Integrated multi-omic analysis of esthesioneuroblastomas identifies two subgroups linked to cell